Literature DB >> 11343988

Outcome of heart transplantation in patients previously infected with hepatitis C virus.

M Castella1, G Tenderich, M M Koerner, L Arusoglu, A El-Banayosy, U Schulz, B Schulze, S Schulte-Eistrup, C Wolff, K Minami, R Koerfer.   

Abstract

The lack of knowledge about the course of hepatitis C virus infection (HCV) before heart transplantation (HTx) prompted us to describe our experience with 4 such patients who presented with positive HCV serology before surgery. Two experienced non-liver related deaths at 3.5 and 5 years after HTx, and none of the patients developed signs of hepatic insufficiency during the follow-up (mean 3.8 years). Tests for HCV antibodies were frequently negative, whereas viral RNA was detected in 81% of the measurements, showing that virus detection techniques seem to be more sensitive than serology techniques in detecting HCV infection in this group of patients. Although immunosuppression promotes active HCV replication, it does not seem to change the chronic features of HCV infection during the first years in patients with good liver function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11343988     DOI: 10.1016/s1053-2498(00)00198-4

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  2 in total

1.  Decreased post-transplant survival among heart transplant recipients with pre-transplant hepatitis C virus positivity.

Authors:  Ingi Lee; Russell Localio; Colleen M Brensinger; Emily A Blumberg; Ebbing Lautenbach; Leanne Gasink; Valerianna K Amorosa; Vincent Lo Re
Journal:  J Heart Lung Transplant       Date:  2011-07-20       Impact factor: 10.247

Review 2.  Treatment of hepatitis C in solid organ transplantation.

Authors:  Susan E Chan; Jonathan M Schwartz; Hugo R Rosen
Journal:  Drugs       Date:  2004       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.